Skip to main content

Advertisement

Log in

The incidence of Proteus mirabilis infection increases in patients on treatment but does not trigger disease activity

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The aim of this study is to determine whether treatment increases the levels of anti-Proteus antibodies (APA) in patients with rheumatoid arthritis (RA). The blood samples of 32 patients suffering from RA who were recruited in our previous study and continued to participate in our follow-up study were collected after 1 year. Their first and follow-up samples were analysed for the presence of IgG isotype and total immunoglobulins (IgG+IgA+IgM) against Proteus mirabalis (PM) using enzyme-linked immunosorbent assay with two kinds of antigen preparations: whole bacteria and sodium dodecyl sulphate (SDS) lysed bacterial extract. All patients were treated with methotrexate and hydroxychloroquine with adequate dose of non-steroidal anti-inflammatory drug. After 1 year, 11 patients were in clinical remission [erythrocyte sedimentation rate (ESR) less than 30 mm/h and C-reactive protein (CRP) less than or equal to 10 mg/l], while the rest of the 21 were in the state of active disease. Correlation and Student's t test were used for statistical analysis. APA titres were significantly elevated in patients after 1 year of therapy. However, the rise was not different between patients who were in clinical remission and those in the state of active disease. APA titre increases in the treatment of RA, and the probable mechanisms are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ebringer A, Ptaszynska T, Corbett M, Wilson C, Macafee Y, Avakian H, Baron P, James DCO (1985) Antibodies to Proteus in rheumatoid arthritis. Lancet ii:305–307

    Article  Google Scholar 

  2. Tiwana H, Wilson C, Alvarez A, Abuknesha R, Bansal S, Ebringer A (1999) Cross-reactivity between the rheumatoid arthritis associated motif EQKRAA and structurally related sequences found in Proteus mirabilis. Infect Immun 67(6):2769–2775

    PubMed  CAS  Google Scholar 

  3. McDonagh J, Gray JW, Sykes H, Walker DJ, Bint AJ, Deighton CM (1994) Anti-Proteus antibodies and Proteus organisms in rheumatoid arthritis: a clinical study. Br J Rheumatol 33(1):32–35

    Article  PubMed  CAS  Google Scholar 

  4. Senior BW, Anderson GA, Morley KD, Kerr MA (1999) Evidence that patients with rheumatoid arthritis have asymptomatic ‘non-significant’ Proteus mirabilis bacteria more frequently than healthy controls. J Infect 38(2):99–106

    Article  PubMed  CAS  Google Scholar 

  5. Chandrashekara S, Ramesh MN, Shobha A, Sarvanan Y et al (2003) Proteus mirabilis and rheumatoid arthritis: no associations with disease. Clin Rheumatol 22:218–220

    Article  PubMed  CAS  Google Scholar 

  6. Maki-Ikola O, Lehtinen K, Grantoss K, Vainionpaa R, Taivanen P (1991) Bacterial antibodies in ankylosing spondylitis. Clin Exp Immunol 84:472–475

    PubMed  CAS  Google Scholar 

  7. Maki-Ikola O, Hellgreen R, Karnecud L, Feltelius N, Knutsson L, Grantoros K (1997) Enhanced jejunal production of antibodies to Klebsiella and other enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 56:421–425

    Article  PubMed  CAS  Google Scholar 

  8. Bjarnason I et al (1987) Nonsteroidal anti-inflammatory drug-induced intestinal inflammation in humans. Gastoenterology 93:480–489

    CAS  Google Scholar 

  9. Uejima M, Kinouchi T, Kataoka K, Hiraoka I, Ohnishi Y (1996) Role of intestinal bacterial in ileal ulcer formation in rats treated with a nonsteroidal inflammatory drug. Microbiol Immunol 40(8):553–560

    PubMed  CAS  Google Scholar 

  10. Bjarnason I, Peters TJ (1996) Influence of anti-rheumatic drugs on gut permeability and on the gut associated lymphoid tissue. Bailliere's Clin Rheumatol 10:165–176

    CAS  Google Scholar 

  11. Berg RD, Wommack E, Deitch EA (1998) Immunosuppression and intestinal bacterial overgrowth synergistically promote bacterial translocation. Arch Surg 123(11):1359–1364, November

    Google Scholar 

  12. Bjarnason I, Zanelli G, Smith T et al (1987) The pathogenesis and consequence of non-steroidal anti-inflammatory drug induced small intestinal inflammation in man. The pathogenesis and consequence of non-steroidal anti-inflammatory drug induced small intestinal inflammation in man. Scand J Rheumatol Suppl 64:55–62

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Chandrashekara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chandrashekara, S., Patil, R., Vadiraja, H.S. et al. The incidence of Proteus mirabilis infection increases in patients on treatment but does not trigger disease activity. Clin Rheumatol 25, 520–523 (2006). https://doi.org/10.1007/s10067-005-0090-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-005-0090-4

Keywords

Navigation